SEARCH

SEARCH BY CITATION

References

  • 1
    Roelofs AAJ,Karssemeijer N,Wedekind N,Beck C,van Woudenberg S,Snoeren PR,Hendriks JHCL,Rosselli del Turco M,Bjurstam N,Junkermann H,Beijerinck D,Séradour B, et al. Importance of comparison of current and prior mammograms in breast cancer screening. Radiology 2007; 242: 707.
  • 2
  • 3
    PerryN,BroedersM,de WolfC,TörnbergS,HollandR,von KarsaL, eds. European guidelines for quality assurance in breast cancer screening and diagnosis,4th edn., Luxembourg: Office for Official Publications of the European Communities, 2006.
  • 4
    Laya MB,Larson EB,Taplin SH,White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88: 6439.
  • 5
    Persson I,Thurfjell E,Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997; 15: 32017.
  • 6
    Kavanagh AM,Mitchell H,Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 2000; 355: 2704.
  • 7
    Séradour B,Estève J,Heid P,Jacquemier J. Hormone replacement therapy and screening mammography: analysis of the results of the Bouches du Rhone programme. J Med Screen 1999; 6: 99102.
  • 8
    Banks E,Reeves G,Beral V,Bull D,Crossley B,Simmonds M,Hilton E,Bailey S,Barrett N,Briers P,English R,Jackson A, et al. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect. Breast Cancer Res 2006; 8: R8.
  • 9
    Kavanagh AM,Cawson J,Byrnes GB,Giles GG,Marr G,Tong B,Gertig DM,Hopper JL. Hormone replacement therapy, percent mammographic density and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev 2005; 14: 10604.
  • 10
    Chiarelli AM,Kirsh VA,Klar NS,Shumak R,Jong R,Fishell E,Yaffe MJ,Boyd NF. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol Biomarkers Prev 2006; 15: 185662.
  • 11
    Njor SH,Olsen AH,Bellstrøm T,Dyreborg U,Bak M,Axelsson C,Graversen HP,Schwartz W,Lynge E. Mammography screening in the county of Fyn November 1993–December 1999. APMIS 2003 ( Suppl); 110: 133.
  • 12
    Gaist D,Sørensen HT,Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 4458.
  • 13
    www.whocc.no/atcddd [Accessed 13 July 2007].
  • 14
    www.medstat.dk [Accessed 15 November 2004].
  • 15
    Njor SH,Olsen AH,Schwartz W,Vejborg I,Lynge E. Predicting life time risk of a false positive test in mammography screening. J Med Screen 2007; 14: 947.
  • 16
    Banks E,Reeves G,Beral V,Bull D,Crossley B,Simmonds M,Hilton E,Bailey S,Barrett N,Briers P,English R,Jackson A, et al. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. BMJ 2004; 329: 4779.
  • 17
    Sumkin JH,Holbert BL,Herrmann JS,Hakim CA,Ganott MA,Poller WR,Shah R,Hardesty LA,Gur D. Optimal reference mammography: a comparison of mammograms obtained 1 and 2 years before the present examination. AJR Am J Roentgenol 2003; 180: 3436.
  • 18
    Gabrielsson J,Wallenbeck I,Birgerson L. Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics. Acta Obstet Gynecol Scand Suppl 1996; 163: 2631.
  • 19
    Notelovitz M,Funk S,Nanavati N,Mazzeo M. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 2002; 99: 55662.
  • 20
    Lynge E,Olsen AH,Fracheboud J,Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003; 12: 21322.
  • 21
    Fracheboud J,de Koning HJ,Boer R,Groenewoud JH,Verbeek AL,Broeders MJ,van Ineveld BM,Hendriks JH,de Bruyn AE,Holland R,van der Maas PJ;National Evaluation Team for Breast cancer screening in The Netherlands. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001; 10: 610.
  • 22
    Otten JD,Karssemeijer N,Hendriks JH,Groenewoud JH,Fracheboud J,Verbeek AL,de Koning HJ,Holland R. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 2005; 97: 74854.